20 results
8-K
EX-99.1
ABSI
Absci Corp
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
to the fight against cancer.
Continued adding talent to growing AI team, now including experience from OpenAI, Meta, Tesla, Google Brain, Roivant
8-K
EX-99.1
ABSI
Absci Corp
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm
collaborations with Merck and NVIDIA, and included continued strengthening of our platform, talent, and infrastructure, paving the way for an already
PRE 14A
ABSI
Absci Corp
11 Apr 23
Preliminary proxy
5:49pm
the past year, especially given our current nimble size and challenging market dynamics. Despite this, we have recruited unmatched talent to our … combination of proprietary data and a world-leading AI platform to capitalize on it, we will continue to recruit top talent in both AI and biology. Our
8-K
EX-99.1
ABSI
Absci Corp
8 Jan 24
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
7:08am
: 16 Active Programs* Absci’s talent and Infrastructure for Better Biologics Faster, at Lower Cost Trademarks, service marks or trade names referred
ARS
n57kii ndbzd5c8cq6cw
28 Apr 23
Annual report to shareholders
12:00am
ARS
090kd8vj0ema2w4m7
23 Apr 24
Annual report to shareholders
4:10pm
10-Q
bhl me1cvttf46ri8pl
7 Sep 21
Quarterly report
8:48am
10-K
9gtjs052
22 Mar 22
Annual report
5:20pm
DRS/A
wnjx9bk65talg
16 Jun 21
Draft registration statement (amended)
12:00am
S-1
3xesf
30 Jun 21
IPO registration
3:20pm
424B4
sqkwjt paa
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
mnlqpqu4
8 Jul 21
IPO registration (amended)
5:04pm
DRS
y2u 5a434fg
6 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next